Joel Bruegger

Joel Bruegger has a diverse work experience spanning from research and development in the biotechnology industry to academia. Joel is currently the Director of Protein Sciences and Process Development at Parvus Therapeutics Inc, where they lead the planning and generation of materials for platform development. Prior to this role, Joel was the Associate Director of Protein Science and Process Development at the same company, where they managed and ran experiments involving protein production, conjugation, and process development activities. Before joining Parvus Therapeutics, they served as a Senior Scientist, driving the initial development activities of biologics for autoimmune disease therapies and streamlining protein expression, purification, and conjugation procedures. Joel also worked as a Scientist at BioElectron Technology Corporation, specializing in enzymology and conducting mechanism of action studies between compounds and enzyme targets. Joel made significant contributions to the identification of the primary enzyme target and mode of inhibition of the company's lead compound. In academia, Joel held positions as a Postdoctoral Research Fellow at UC Berkeley and as a Research Associate at The Scripps Research Institute. Joel completed their PhD in Biological Sciences at UC Irvine, where their research focused on protein-protein and protein-substrate interactions between carrier proteins and FAS/PKS enzyme partners. Joel began their career as a Research Assistant at Hitachi Chemical Diagnostics, Inc, where they were involved in the development of an in vitro diagnostic device to quantify patient reactions to allergens. Overall, Joel Bruegger has a strong background in protein sciences, process development, enzymology, and academic research.

Joel Bruegger began their education journey in 2001 at the College of San Mateo, where they studied Biology, General. Joel continued their studies at the University of California, Davis from 2003 to 2005, earning a Bachelor of Science (BS) degree in Biochemistry and Molecular Biology. Seeking further specialization, Joel enrolled at UC Irvine from 2007 to 2013, where they successfully completed a PhD in Biological Sciences.